Carmustine Kit
Product Images NDC 75907-327

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carmustine (NDC 75907-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This text appears to be a description of the medication Carmustine for Injection, USP. This medication comes in single-dose vials containing 100 mg per vial. It is intended for intravenous infusion after reconstitution with a sterile diluent and water for injection. The reconstituted solution must be refrigerated and discarded after 24 hours. The prescription information, dosage, and precautions are detailed in the enclosed package insert. The distributor of this medication is Dr. Reddy’s Laboratories Inc., and it is made in India. Please refer to the enclosed package insert for further details and directions on storage and usage.*

FDA Label Image

Diluent (Diluent)

This text describes a pharmaceutical product containing dehydrated alcohol for injection, which is used as a sterile diluent for Carmustine for Injection. The product is distributed by Dr. Reddy’s Laboratories Inc. and should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F). It also mentions the trademark Novaplus and provides additional information such as lot number and expiration date.*

FDA Label Image

Label (Label)

This is a description of Carmustine for Injection, USP. It contains 100 mg per Vial and is a Single-Dose Vial for intravenous infusion after reconstitution. The medication needs to be refrigerated immediately and any unused portion must be discarded. The text provides storage instructions and details about the recommended reconstitution process. It also mentions the usual dosage and that it is a Cytostatic Agent. The text includes information about the shelf life of the reconstituted solution and the appearance of the vial. Additionally, it states that the product is not returnable.*

FDA Label Image

Ifs (Ifs)

This text provides step-by-step instructions for using the COMBI KIT guard, including removing the flip seals from vials, withdrawing sterile diluent with a syringe, injecting it into the vial containing carmustine, shaking to dissolve the contents, and adding sterile water for injection. These detailed instructions are useful for ensuring proper preparation and administration of the medication.*

FDA Label Image

Ifu2 (Ifu2)

Instructions for step 8 of a process involving the aseptic removal of diluted product and infusion. The COMBI KIT guard should be held firmly by hand and shaken gently after further dilution with either Sodium Chloride for Injection, USP or 5% Dextrose Injection.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.